This minor release fixes an issue present since v1.4.1 where non-LIMS genes were being considered for maximum MDL drug interpretation. This corrects this issue so that only LIMS genes are considered for maximum drug interpretation.
Only for use with WHO v1 catalogue and TBProfiler v4.4.2